Does ELOTUZUMAB Cause Pulmonary embolism? 50 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Pulmonary embolism have been filed in association with ELOTUZUMAB (EMPLICITI). This represents 1.5% of all adverse event reports for ELOTUZUMAB.
50
Reports of Pulmonary embolism with ELOTUZUMAB
1.5%
of all ELOTUZUMAB reports
15
Deaths
35
Hospitalizations
How Dangerous Is Pulmonary embolism From ELOTUZUMAB?
Of the 50 reports, 15 (30.0%) resulted in death, 35 (70.0%) required hospitalization, and 13 (26.0%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for ELOTUZUMAB.
What Other Side Effects Does ELOTUZUMAB Cause?
Plasma cell myeloma (339)
Death (234)
Malignant neoplasm progression (227)
Pneumonia (209)
Pyrexia (183)
Drug ineffective (137)
Neutropenia (133)
Anaemia (119)
Thrombocytopenia (107)
Diarrhoea (105)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which ELOTUZUMAB Alternatives Have Lower Pulmonary embolism Risk?
ELOTUZUMAB vs ELOXATIN
ELOTUZUMAB vs ELRANATAMAB
ELOTUZUMAB vs ELRANATAMAB-BCMM
ELOTUZUMAB vs ELTROMBOPAG
ELOTUZUMAB vs ELTROMBOPAG OLAMINE